Regent Investment Management LLC Abbott Laboratories Transaction History

Regent Investment Management LLC

$373 Million
Q4 2022

A detailed history of Regent Investment Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Regent Investment Management LLC holds 17,302 shares of ABT stock, worth $1.8 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

17,302

Previous 17,302 -0.0%

Holding current value

$1.8 Million

Previous $1.67 Million 13.5%

% of portfolio

0.51%

Previous 0.49%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $20,414 - $24,674	-200 Reduced 1.14%	17,302 $1.88 Million
Q1 2022 Apr 19, 2022	SELL	$114.02 - $139.04 $6,271 - $7,647	-55 Reduced 0.31%	17,502 $2.07 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $30,615 - $37,486	265 Added 1.53%	17,557 $2.47 Million
Q1 2021 Apr 20, 2021	SELL	$108.84 - $128.23 $43,536 - $51,291	-400 Reduced 2.26%	17,292 $2.07 Million
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $113,295 - $123,459	-1,079 Reduced 5.75%	17,692 $1.94 Million

Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $123,714 - $150,241	-1,350 Reduced 6.71%	18,771 $2.04 Million
Q2 2020 Jul 29, 2020	BUY	$76.57 - $98.0 $193,262 - $247,352	2,524 Added 14.34%	20,121 $1.84 Million
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $84,430 - $123,459	-1,344 Reduced 7.1%	17,597 $1.39 Million
Q4 2019 Jan 30, 2020	SELL	$78.51 - $87.4 $3,611 - $4,020	-46 Reduced 0.24%	18,941 $1.65 Million
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $508,553 - $551,430	-6,214 Reduced 24.66%	18,987 $1.59 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $201,148 - $234,600	-2,760 Reduced 9.87%	25,201 $2.12 Million
Q1 2019 Apr 22, 2019	SELL	$66.22 - $80.06 $85,092 - $102,877	-1,285 Reduced 4.39%	27,961 $2.24 Million
Q3 2018 Oct 22, 2018	SELL	$60.81 - $73.36 $187,902 - $226,682	-3,090 Reduced 9.56%	29,246 $2.15 Million
Q2 2018 Jul 16, 2018	BUY	$57.57 - $63.54 $6,102 - $6,735	106 Added 0.33%	32,336 $1.97 Million
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $61,897 - $69,982	-1,100 Reduced 3.3%	32,230 $1.93 Million
Q4 2017 Jan 26, 2018	BUY	$53.68 - $57.47 $42,246 - $45,228	787 Added 2.42%	33,330 $1.9 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $1.56 Million - $1.75 Million	32,543	32,543 $1.74 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.

Account

Regent Investment Management LLC Abbott Laboratories Transaction History